Application 021343

Type
NDA
Sponsor
TOLMAR THERAP

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ELIGARDLEUPROLIDE ACETATEINJECTABLE;SUBCUTANEOUS7.5MG/VIALYesYes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N021343-001ELIGARD KITLEUPROLIDE ACETATE7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-23

Orange Book patents#

Current patent rows page 1 of 1 · 3 matching rows.

Application-product, Patent, Expiration table
Application-productPatentExpirationUse codeCoverage / statusSubmission date
N021343-001117718412041-12-22Drug substance, Drug product2023-10-27
N021343-001119315592041-12-22Drug substance2024-04-15
N021343-001123971202041-12-22U-40012025-09-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-23011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-2331067a03dcf5…
2025-08-23 18:47 UTC2025-08N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-236a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-23fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-23b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-2303ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-232680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-235bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-23d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-23d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-2379d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-23301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-231e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-238072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-235c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-235d02ea3f76ae…
2022-04-04 05:41 UTC2022-04N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-234b0b4de00fa7…
2019-12-13 00:20 UTC2019-12N021343-001ELIGARD7.5MG/VIALINJECTABLE / SUBCUTANEOUSRLD, RS2002-01-2374a2ff9319b5…
2022-03-09 01:35 UTC2022-03N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-23bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-23782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-2387673890dc5c…
2021-03-12 10:30 UTC2021-03N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-235aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-238869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-23c0c555d07b60…
2019-12-14 00:12 UTC2019-12N021343-001ELIGARD7.5MG/VIALINJECTABLE / SUBCUTANEOUSRLD, RS2002-01-233f01610625f2…
2019-09-15 20:21 UTC2019-09N021343-001ELIGARD7.5MG/VIALINJECTABLE / SUBCUTANEOUSRLD, RS2002-01-23b00525d2431f…
2019-07-19 19:46 UTC2019-07N021343-001ELIGARD7.5MG/VIALINJECTABLE / SUBCUTANEOUSRLD, RS2002-01-23ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-236a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-231c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-23ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-23a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-239b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-23a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-233f0d92c62455…
2023-05-13 08:27 UTC2023-05N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-23053a50430f4f…
2023-01-26 05:58 UTC2023-01N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-233bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-233a93d1ddd44b…
2022-10-28 04:53 UTC2022-10N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-23f41ea6bd6efb…
2022-09-29 23:25 UTC2022-09N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-23e64feba35796…
2022-07-09 03:26 UTC · 3 captures of this ZIP2022-07N021343-001ELIGARD KIT7.5MGPOWDER / SUBCUTANEOUSRLD, RS2002-01-23cb3db0bc1861…

Observed Orange Book patent history#

Patent history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productPatentExpirationUse codeCoverage / statusSubmission dateSource SHA-256
2026-02-19 14:30 UTC2026-02N021343-001117718412041-12-22Drug substance, Drug product2023-10-27011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021343-001119315592041-12-22Drug substance2024-04-15011fe1cb6892…
2026-02-19 14:30 UTC2026-02N021343-001123971202041-12-22U-40012025-09-22011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021343-001117718412041-12-22Drug substance, Drug product2023-10-2731067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021343-001119315592041-12-22Drug substance2024-04-1531067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12N021343-001123971202041-12-22U-40012025-09-2231067a03dcf5…
2025-08-23 18:47 UTC2025-08N021343-001117718412041-12-22Drug substance, Drug product2023-10-276a471c1ec25d…
2025-08-23 18:47 UTC2025-08N021343-001119315592041-12-22Drug substance2024-04-156a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021343-001117718412041-12-22Drug substance, Drug product2023-10-27fd3edfee7708…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03N021343-001119315592041-12-22Drug substance2024-04-15fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021343-001117718412041-12-22Drug substance, Drug product2023-10-27b8a1b40f171c…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02N021343-001119315592041-12-22Drug substance2024-04-15b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021343-001117718412041-12-22Drug substance, Drug product2023-10-2703ed91905a0d…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01N021343-001119315592041-12-22Drug substance2024-04-1503ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021343-001117718412041-12-22Drug substance, Drug product2023-10-272680178bc6a6…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12N021343-001119315592041-12-22Drug substance2024-04-152680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021343-001117718412041-12-22Drug substance, Drug product2023-10-275bbf6a4d5a75…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09N021343-001119315592041-12-22Drug substance2024-04-155bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021343-001117718412041-12-22Drug substance, Drug product2023-10-27d8e5a09893c0…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11N021343-001119315592041-12-22Drug substance2024-04-15d8e5a09893c0…
2024-10-29 15:01 UTC2024-10N021343-001117718412041-12-22Drug substance, Drug product2023-10-27d06236e962d9…
2024-10-29 15:01 UTC2024-10N021343-001119315592041-12-22Drug substance2024-04-15d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021343-001117718412041-12-22Drug substance, Drug product2023-10-2779d66fd596c7…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08N021343-001119315592041-12-22Drug substance2024-04-1579d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021343-001117718412041-12-22Drug substance, Drug product2023-10-27301d65b070ca…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07N021343-001119315592041-12-22Drug substance2024-04-15301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021343-001117718412041-12-22Drug substance, Drug product2023-10-271e350fbaab3a…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06N021343-001119315592041-12-22Drug substance2024-04-151e350fbaab3a…
2024-05-31 18:47 UTC2024-05N021343-001117718412041-12-22Drug substance, Drug product2023-10-278072bd15b7f6…
2024-05-31 18:47 UTC2024-05N021343-001119315592041-12-22Drug substance2024-04-158072bd15b7f6…
2019-12-13 00:20 UTC2019-12N021343-00166268702020-03-27Drug product74a2ff9319b5…
2020-12-22 03:56 UTC2020-12N021343-00166268702020-03-27Drug product8869cabd3fbd…
2020-11-12 02:37 UTC2020-11N021343-00166268702020-03-27Drug productc0c555d07b60…
2019-12-14 00:12 UTC2019-12N021343-00166268702020-03-27Drug product3f01610625f2…
2019-09-15 20:21 UTC2019-09N021343-00166268702020-03-27Drug productb00525d2431f…
2019-07-19 19:46 UTC2019-07N021343-00166268702020-03-27Drug productea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03N021343-001117718412041-12-22Drug substance, Drug product2023-10-276a51e52b5d6a…
2024-02-18 07:12 UTC2024-02N021343-001117718412041-12-22Drug substance, Drug product2023-10-271c564ffb4f44…
2023-12-20 04:57 UTC2023-12N021343-001117718412041-12-22Drug substance, Drug product2023-10-27ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N021343-001117718412041-12-22Drug substance, Drug product2023-10-27a72a2bbeb626…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VabrintyLEUPROLIDE ACETATEURONOVA PHARMACEUTICALS, INC.008776cc-83f1-4f8c-819b-6471425da15f2026-04-30Warnings, Adverse reactionsExact identifier
application applno (NDA): 021343
application number: NDA021343
EligardLEUPROLIDE ACETATETOLMAR Inc.b7b679a9-6823-4ef8-8d31-3ab5058ffcfc2026-04-30Warnings, Adverse reactionsExact identifier
application applno (NDA): 021343
application number: NDA021343
ELIGARDLEUPROLIDE ACETATETOLMAR Inc.b78d1919-9dee-44fa-90f9-e0a26d32481d2019-04-29Warnings, Adverse reactionsExact identifier
application applno (NDA): 021343
application number: NDA021343
ndc (product): 62935-753

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 13 matching rows.

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
62935-752ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-753ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-753ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-753ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-753ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-753ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-753ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-753ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-753ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-753ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-753ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-753ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent
62935-753ELIGARDLeuprolide AcetateTOLMAR PHARMACEUTICALS INC.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85887SUPPL 2026-05-12
85852SUPPL 2026-05-08
81369SUPPL 2025-02-25
81344SUPPL 2025-02-25
81013SUPPL 2025-02-06
80963SUPPL 2025-02-06
78527SUPPL 2024-05-22
78526SUPPL 2024-05-22
77293SUPPL 2024-01-25
77285SUPPL 2024-01-24
74858SUPPL 2023-07-21
74856SUPPL 2023-07-21
74847SUPPL 2023-07-21
74846SUPPL 2023-07-21
57733SUPPL2019-02-21
57696SUPPL2019-02-19
15225SUPPL2016-03-03
27529SUPPL2016-03-02
44988SUPPL2016-02-29
36699SUPPL2014-10-15
5094SUPPL2014-10-14
15224SUPPL2013-03-01
5093SUPPL2013-03-01
23647ORIG2011-12-20
36698SUPPL2011-04-11
5092SUPPL2011-04-11
27528SUPPL2011-01-20
15223SUPPL2011-01-20
27527SUPPL2010-10-13
36697SUPPL2010-10-12
5091SUPPL2007-11-19
36696SUPPL2007-11-13
27526SUPPL2004-01-14
5090SUPPL2003-07-08
5089SUPPL2002-04-01
36695ORIG2002-01-23
27525ORIG2002-01-23
21610ORIG2002-01-23